 Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati
Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati Firstsource and Monash University Sign Strategic MoU
Firstsource and Monash University Sign Strategic MoU Deep Diamond India Limited declares interim dividend of Rs. 0.10
Deep Diamond India Limited declares interim dividend of Rs. 0.10 Steelcast Ltd declares 2nd interim dividend of Rs. 0.36
Steelcast Ltd declares 2nd interim dividend of Rs. 0.36 Lancor Holdings Ltd gets favorable verdict from SC in commercial property case
Lancor Holdings Ltd gets favorable verdict from SC in commercial property case 
              Rating: BUY, TP: Rs330, Upside: 34%)
- Greenpanel Industries Ltd (GIL)'s Q1FY22 performance was impacted due to 2nd wave of COVID-19 in domestic markets. Plywood volumes witnessed sharp decline of 42.6% q/q in volume terms & 45.3% q/q in value terms. MDF segment witnessed 19% q/q degrowth in volume terms & 15.8% in value terms in Q1FY22. We believe with re-opening of economy in domestic markets, retail demand (68% of domestic volumes) should bounce back.
- We continue to remain bullish on the company on account of (i) rapid displacement of mid-lowend plywood segment by MDFs, (ii) growing trend of online furniture in India and (iii) replacement of imports by domestic players (imports ~18-20% of total demand). Moreover, to cater the increase in demand company is enhancing their capacity by 20% to ~660,000cmb/annum. Hence, we expect MDF volumes to grow by 18% over FY21-FY23E.
- Going ahead we factor in Revenue/EBITDA/PAT CAGR of 18.5%/29.2%/77.3% over FY21-23E respectively. Moreover, with company's aim to strengthen its balance sheet, we expect net debt/EBITDA to decline from 1.8x in FY21 to 0.1x in FY23E.
- AT CMP, GIL is trading at 14.2x on FY23E EPS of Rs17.6. We continue to value the company at 18.5x on FY23E EPS arriving at a target price of Rs330. Hence, we maintain our BUY rating on the stock".